Saxenda vs Wegovy: Which weight loss drug is right for you?
Saxenda (liraglutide) and Wegovy (semaglutide) are two prescription medications used with diet and exercise for weight loss and long-term weight management in certain people 12 years and older. Wegovy is additionally approved to lower the risk of major adverse cardiovascular events, like heart attack and stroke, in adults who are obese or overweight.
Both medications are marketed by Novo Nordisk. They come as pre-filled, single-dose pens and the medication is injected under the skin.
When choosing a weight loss treatment, there are several factors to consider. These include side effects, warnings, cost, and dosing. Below is a comparison between Saxenda and Wegovy for weight loss. Talk to your healthcare provider if you have questions about these medications.
What are the approved uses for Saxenda and Wegovy?
Saxenda and Wegovy are FDA approved for long-term weight management, in combination with diet and exercise. In addition, Wegovy has cardioprotective effects and can be used to reduce the risk of major adverse cardiovascular events, such as heart attack and stroke, in adults who are obese or overweight.
Saxenda
Saxenda is approved for long-term weight management in adults with a body mass index (BMI) of 30 kg/m2 or greater or 27 kg/m2 or greater with at least one weight-related condition. It is also approved in children 12 years and older with a body weight greater than 60 kg and a BMI corresponding to 30 kg/m2 for adults.
Wegovy
Wegovy is approved for long-term weight management in adults and children 12 years and older who are obese, and adults who are overweight and have at least one weight-related condition. It is also approved in adults with obesity or overweight to lower the risk of major adverse cardiovascular events.
How do Saxenda and Wegovy work?
Both Saxenda and Wegovy belong to a drug class called glucagon-like peptide-1 (GLP-1) receptor agonists. They mimic the natural GLP-1 hormone found in our bodies. They work by slowing down food movement through your stomach, which makes you feel fuller longer. This lowers your appetite and leads to weight loss.
Saxenda and Wegovy should not be used together, or with other GLP-1 receptor agonists.
How are Saxenda and Wegovy given?
Saxenda and Wegovy are given as injections under the skin, but their dosing frequency and doses are different. You or a caregiver can get trained on how to give the injections at home using the pre-filled injector pens.
Saxenda comes in 6 mg/mL in a 3 mL pre-filled pen that provides the following doses:
- 0.6 mg
- 1.2 mg
- 1.8 mg
- 2.4 mg
- 3 mg
The dose is typically started low and slowly raised to the maintenance dose. Saxenda is injected under the skin in the stomach, thigh, or upper arm once a day. You can inject the medication with or without food.
Wegovy comes in the following pen injectors:
- 0.25 mg/0.5 mL
- 0.5 mg/0.5 mL
- 1 mg/0.5 mL
- 1.7 mg/0.75 mL
- 2.4 mg/0.75 mL
Similar to Saxenda, Wegovy is started at a low dose and slowly titrated up every 4 weeks. It is injected under the skin in the stomach, thigh, or upper arm once a week. It can be injected without regard to meals.
How do Saxenda and Wegovy compare in studies?
The STEP 8 trial compared Saxenda and Wegovy directly to see the effects of each medication on body weight. Patients took either 3 mg of Saxenda daily or 2.4 mg of Wegovy weekly. Researchers found that patients who took Saxenda lost 6.4% of their body weight over 68 weeks, compared to 15.8% with Wegovy.
Side effects were similar among patients in the study. About 84% of patients reported stomach-related side effects with Wegovy, and 83% reported them with Saxenda.
Related questions
- Saxenda vs Ozempic: For Weight Loss?
- Why am I not losing weight on Saxenda?
- What foods should I avoid while on Saxenda?
How do the side effects compare between Saxenda and Wegovy?
Side effects of Saxenda and Wegovy are similar. The most common side effects of both medications are stomach-related, such as nausea, vomiting, and diarrhea. For most people, episodes are mild or moderate and occur more often during the time the dose is raised. Slowly raising the dose can help reduce stomach side effects from these medications.
Saxenda side effects
The most common side effects in adults using Saxenda during clinical trials were:
- Nausea (39%)
- Diarrhea (21%)
- Constipation (19%)
- Vomiting (16%)
- Injection site reaction (14%)
- Headache (14%)
- Low blood sugar in people with type 2 diabetes (13%)
- Indigestion (10%)
Other side effects include feeling tired, dizziness, stomach pain, bloating, belching, urinary tract infection, and excessive gas.
The side effects in children were similar to those reported by adults. These are not all possible side effects from Saxenda. Review potential side effects of this medication with your healthcare provider.
Wegovy side effects
The most common side effects in adults using Wegovy during clinical trials were:
- Nausea (44%)
- Diarrhea (30%)
- Vomiting (24%)
- Constipation (24%)
- Stomach pain (20%)
- Headache (14%)
- Fatigue (11%)
Other side effects reported included indigestion, dizziness, bloating, belching, low blood sugar in people with type 2 diabetes, and excessive gas. These are not all possible side effects from Wegovy.
Both Saxenda and Wegovy carry Boxed Warnings for an increased risk of thyroid tumors, including cancer. While this has been seen in animal studies, it is not known if these medications cause these problems in humans.
Do not use these medications if:
- you or your family has a history of medullary thyroid carcinoma (MTC), or
- if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Symptoms of thyroid tumors can include a mass in the neck, trouble swallowing, shortness of breath, or persistent hoarseness.
Cost comparison
Saxenda and Wegovy are available as brand-name products only. There are no generic versions available.
Saxenda cost:
- 18 mg/3mL subcutaneous injection: $1,430 for a one month supply
Wegovy cost:
- Wegovy subcutaneous injection: $1,430 for a one month supply
The prices above are for cash-paying customers and are not valid with insurance plans. Prices are based on the Drugs.com discount card and are subject to change.
If you have insurance, the amount you pay for these medications will depend on your coverage for prescription drugs, deductible, and copay. The manufacturer may offer a copay coupon that you might be eligible to use with your commercial insurance.
This is not all the information you need to know about Saxenda (liraglutide) and Wegovy (semaglutide) for safe and effective use and does not take the place of your doctor’s directions. Review the full patient medication guide and discuss this information and any questions you have with your doctor or other health care provider.
References
Rubino, D. M., et. al. 2022. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes. In: JAMA. DOI: https://doi.org/10.1001/jama.2021.23619
Saxenda [package insert]. Updated November 2024. Novo Nordisk. Accessed 01/08/2025 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143
Wegovy [package insert]. Updated November 2024. Novo Nordisk. Accessed 01/08/2025 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
Read next
How and where do you inject liraglutide?
Liraglutide is injected just under the skin (subcutaneously) and the best sites are your stomach (abdomen), thigh, or upper arm. Do not inject Victoza into a muscle (intramuscularly) or vein (intravenously). To do this, you pinch up an area of skin with your thumb and forefinger, and then push the needle of the pen into this area, so that the medication will be injected just under the skin. Ask your doctor, nurse, or pharmacist to show you how to use the pen correctly before your first use. Continue reading
Can liraglutide be used for weight loss?
Yes, the Saxenda brand of liraglutide is approved to be used for weight loss. The Victoza brand of liraglutide is only approved to treat type 2 diabetes, but may also help you lose some weight and protect your heart. A generic liraglutide option for Victoza for treatment of type 2 diabetes was FDA-approved on December 23, 2024. Do not use Saxenda, Victoza or other liraglutide products at the same time. Continue reading
Ozempic Side Effects to Watch For
The most common Ozempic side effects with Ozempic include stomach problems, like nausea, vomiting, diarrhea, stomach pain and constipation. These tend to be mild-to-moderate and usually clear up in a few weeks in most people. Low blood sugar (hypoglycemia) is also a common side effect (when used with certain other diabetes treatments) and it can be serious. Continue reading
Related medical questions
- What options are there for weight loss medications?
- 6 Wegovy side effects you need to be aware of
- How do Ozempic, Mounjaro, Wegovy, Zepbound compare for weight loss?
- Wegovy vs Ozempic: Which is Right for You?
- How long to see weight loss results with Wegovy?
- Do Ozempic, Wegovy, Mounjaro & Zepbound cause hair loss?
- Can you get tirzepatide from a compounding pharmacy?
- How do Zepbound and Wegovy compare?
- Does Ozempic cause muscle loss and how to prevent it?
- How do you get Wegovy covered by insurance?
- Ozempic Face: What causes it and how to prevent it?
- Do GLP-1 drugs like Ozempic or Wegovy affect bone density?
- When is the best time of day to take Wegovy?
- Can you just stop taking Rybelsus?
- Is Ozempic covered by Medicare and Medicaid?
- Does Wegovy make you pee a lot or urine smell?
- How does Wegovy work for weight loss?
- Is Wegovy covered by Medicare?
- Can Ozempic and Wegovy cause blindness?
- Can Wegovy or Ozempic be used for heart failure?
- Wegovy coupon card: Do I qualify and how much can I save?
- What's the buzz on Ozempic and Wegovy?
Drug information
Related support groups
- Saxenda (62 questions, 383 members)
- Wegovy (43 questions, 112 members)
- Weight Loss (Obesity/Overweight) (846 questions, 1,505 members)
- Cardiovascular Risk Reduction (97 questions, 28 members)